Disseminated Mycobacterium Bovis after Intravesicular Bacillus Calmette-Guérin Treatments for Bladder Cancer-Reference-Cited by-同舟云学术

Disseminated Mycobacterium Bovis after Intravesicular Bacillus Calmette-Guérin Treatments for Bladder Cancer

Published:2000-09 Issue:5 Volume:7 Page:476-481
ISSN:1073-2748
Container-title:Cancer Control
language:en
Short-container-title:Cancer Control

Author:

Elkabani Magda¹,Greene John N.¹,Vincent Albert L.¹,Vanhook Steven¹,Sandin Ramon L.²

Affiliation:

1. Department of Medicine, Division of Infectious and Tropical Diseases, University of South Florida College of Medicine and the H. Lee Moffitt Cancer Center & Research Institute, Tampa, Fla.

2. Department of Pathology, University of South Florida College of Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Fla.

Publisher

SAGE Publications

Subject

Oncology,Hematology,General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/107327480000700512

Reference20 articles.

1. Bacillus Calmette-Guerin for Superficial Transitional Cell Carcinoma of the Bladder

2. Bacille Calmette-Guerin in superficial transitional cell carcinoma

3. Complications of Bacillus Calmette-Guerin Immunotherapy in 1,278 Patients with Bladder Cancer

4. Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative analysis of adverse events among intravesical drugs in bladder cancer: a real-world study on FAERS database;Expert Opinion on Drug Safety;2024-07-04

2. Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria;Pharmaceutics;2023-07-21

3. A case of disseminated M. bovis bacillus Calmette-Guérin (BCG) disease after one month of BCG bladder infusion therapy and analysis of 77 cases of suspected BCG infection in Japan, 2017–2022;Respiratory Medicine Case Reports;2023

4. Culture-proven disseminated Mycobacterium Bovis infection (BCG-Osis) following intravesical BCG immunotherapy in a patient with bladder carcinoma-in-situ: ‘Case report’;African Journal of Urology;2022-02-14

5. Clinical features of tuberculous pseudoaneurysm and risk factors for mortality;Journal of Vascular Surgery;2021-11